Core Insights - Microbix Biosystems Inc. hosted Ontario Premier Doug Ford and MPP Deepak Anand to discuss the impact of next-generation diagnostic tests on health outcomes and healthcare costs [1][2] - The company has received over C2.0millioningrantfundingfromtheOntarioTogetherFunds,whichhassupportedthedevelopmentofinnovativehealthcareproducts[2]−MicrobixisrecognizedasaleadinglifesciencescompanyinOntario,focusingonthemanufacturingandexportofdiagnosticproducts[2][3]CompanyOverview−MicrobixBiosystemsInc.specializesinproprietarybiologicalproductsforhumanhealth,employingover120skilledworkersandtargetingmonthlysalesofC 2.0 million or more [3] - The company produces critical ingredients for the global diagnostics industry, including antigens for immunoassays and laboratory quality assessment products (QAPs™) [3][4] - Microbix's QAPs are sold in over 30 countries and are used by clinical lab accreditation organizations and diagnostics companies [3] Product Development - The company is also involved in developing proprietary products such as Kinlytic urokinase, a thrombolytic drug for treating blood clots, and reagents for molecular diagnostic testing [4] - Microbix is ISO 9001 & 13485 accredited, U.S. FDA registered, and provides IVDR-compliant CE marked products [3]